SCHEMBL470190

SCHEMBL470190

CNC(=O)c1ccc(-c2cnc3c(NCc4cccs4)cc(Cl)nn23)cc1

nearest known ligand 0.48

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TTK P33981 4/20 0.48
FYN P06241 14/20 0.47
POLB P06746 1/20 0.44
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL470191 0.89 FYN (0.47) TTKFYNPOLB
SCHEMBL10279098 0.89 FYN (0.46) FYNPOLB
SCHEMBL470013 0.88 CYP1A2 (0.54) TTKFYNPOLB
SCHEMBL10279181 0.82 TTK (0.59) TTKFYN
SCHEMBL10279096 0.80 FYN (0.41) TTKFYNHDAC1HDAC6
SCHEMBL10279097 0.79 TTK (0.51) TTK
SCHEMBL470001 0.76 KCNN1 (0.44) FYNPOLBHDAC3HDAC1HDAC2
SCHEMBL10279183 0.74 TTK (0.58) TTKFYN
SCHEMBL462792 0.71 ERN1 (0.43) TTKFYN
SCHEMBL10279180 0.71 TTK (0.56) TTKFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014020041-A1 COMBINATIONS FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-02-06 WO claimed
US-9255100-B2 Substituted imidazopyridazines BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-02-09 US disclosed
EP-2614063-B1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER IP GMBH (DE) 2016-01-13 EP disclosed
EP-2614063-B1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER IP GMBH (DE) 2016-01-13 EP disclosed
WO-2012032031-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-15 WO disclosed